Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Foghorn Therapeutics at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Foghorn Therapeutics brings 4 presentations to Discovery on Target 2026 in Boston. Its program centres on induced proximity as a way to rewire gene transcription and on computational strategies for proximity-based drugs. It also presents first-in-class ARID1B degraders aimed at ARID1A-mutant cancers.

OrganizationDiscovery on Target 2026 Attendance
Biotech
Clinical-stage biotech targeting the chromatin regulatory system with small molecules and protein degraders for cancer.
Panel
Mon Sep 28
10:45am–11:30am
Implementation of Computational Strategies for Driving Proximity-Induced Therapies
Symposium: Induced Proximity-Based Drug Discovery · with Barcelona Supercomputing Center, InduPro, Novartis
Talk
Mon Sep 28
3:05pm–3:35pm
Rewiring Transcription via Induced Proximity
Symposium: Induced Proximity-Based Drug Discovery
Chair
Tue Sep 29
1:45pm–1:50pm
Chairperson's Remarks
Novel Drug Modalities
Talk
Thu Oct 1
9:05am–9:25am

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Foghorn Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction